Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Hypertension. 2012 Dec 10;61(2):417–424. doi: 10.1161/HYPERTENSIONAHA.112.201889

Table 1.

Effects of treatments on heart and kidney weight

Variable Vehicle
(n=9)
Valsartan
(n=10)
Aliskiren
(n=10)
Combination
(n=10)
WHW/BW (mg/g) 3.85 ± 0.06 3.10 ± 0.03*** 3.25 ± 0.08*** 3.02 ± 0.04***,§
WHW/TL (mg/mm) 36.8 ± 0.5 29.0 ± 0.4*** 30.7 ± 0.2***, 28.1 ± 0.4***,§§§
LVW/BW (mg/g) 2.74 ± 0.04 2.10 ± 0.03*** 2.16 ± 0.05*** 1.97 ± 0.03***,§§§
LVW/TL (mg/mm) 26.2 ± 0.41 19.6 ± 0.24*** 20.4 ± 0.20*** 18.3 ± 0.29***,,§§§
KW/BW (mg/g) 3.82 ± 0.05 3.95 ± 0.10 4.17 ± 0.12 4.35 ± 0.11**,
KW/TL (mg/mm) 36.5 ± 0.4 36.9 ± 0.9 39.5 ± 1.1 40.5 ± 0.9*,

WHW: whole heart weight, BW: body weight, TL: tibia length, LVW: left ventricular weight, KW: kidney weight. Values are means ± SEM.

*

: P<0.05 vs vehicle,

: P<0.05 vs valsartan,

§

: P<0.05 vs aliskiren,

**

: P<0.01 vs vehicle,

***

: P<0.001 vs vehicle,

§§§

: P<0.001 vs aliskiren